CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...